AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration

Active, not recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

January 29, 2020

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Interventions
PROCEDURE

Peripheral blood draw

"* All cohorts will have peripheral blood drawn at baseline no more than 4 days prior to the first dose of chemotherapy and must also occur before the first dose of chemotherapy~* Cohort 0 or 1 - peripheral blood draw on Day 2~* Cohorts 0, 2, 3, 4 and 5 - peripheral blood draw on Day 3~* Cohort 0 or 1 - peripheral blood draw on Day 35 (at count recovery)~* Cohorts 0, 2, 3, 4, and 5 - peripheral blood draw on Cycles 2 or 3 and 4 or 5, Day 28"

PROCEDURE

Bone marrow aspirate

"* Cohort 0 or 1 - bone marrow aspirate on Day 14~* Cohort 0 or 1 - bone marrow aspirate on Day 35 (at count recovery)~* Cohorts 0, 2, 3, 4, and 5 - bone marrow aspirate on Cycles 2 or 3 and 4 or 5, Day 28"

PROCEDURE

Buccal swab

"* Cohort 0 or 1 - buccal swab on Day 35 (at count recovery)~* Cohorts 0, 2, 3, 4, and 5 - buccal swab on Cycle 2 or 3 and 4 or 5, Day 28"

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Notable Labs

INDUSTRY

lead

Washington University School of Medicine

OTHER